CINC - Cincor Pharma, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - CINC (1868734)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
8 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2022-11-28
CINCHealy JamesDir, 10%S - Sale$14.32-6,0000-100%-$85,920
D
2022-06-10
CINCFreeman MasonChief Medical OfficerS - Sale+OE$15.21-60-100%-$91
2022-08-15
CINC5Am Partners Vi, LLC10%P - Purchase$30.00+600,0004,937,646+14%+$18,000,000
2022-08-15
CINCSofinnova Partners Sas10%P - Purchase$30.00+133,3334,220,979+3%+$3,999,990
2022-08-11
CINCSofinnova Venture Partners X, L.P.10%P - Purchase$30.00+500,0006,073,949+9%+$15,000,000
2022-08-11
CINCHealy JamesDir, 10%P - Purchase$30.00+506,0006,109,360+9%+$15,180,000
2022-08-11
CINCGeneral Atlantic Genpar (Bermuda), L.P.10%P - Purchase$30.00+83,0004,209,470+2%+$2,490,000
2022-08-11
CINCGeneral Atlantic, L.P.10%P - Purchase$30.00+83,0004,209,470+2%+$2,490,000

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top